Skip to Content

Join the 'Halotestin' group to help and get support from people like you.

Halotestin News

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. "It is our hope that this information can be used by patients and physicians when discussing the impact of cancer treatment decisions on survival," Johnson said in a school news release. Steve Jobs, co-founder and former CEO of Apple, is likely the most famous person who initially chose alternative medicine as a sole treatment. He eventually turned back to conventional medicine when the alternative medicine treatment didn't keep his pancreatic cancer at bay. But at that point, the cancer had ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Femara, Lupron Depot, Anastrozole, Letrozole, Megestrol, Xeloda, Evista, Pancreatic Cancer, Zoladex, Megace, Herceptin

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Femara, Lupron Depot, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Tarceva, Megestrol

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Letrozole

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 10 Jul 2017 by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," said study lead author Lauren Wallner, an assistant professor of general medicine and epidemiology at the University of Michigan. "Physicians need to recognize that women involve other people in their treatment decisions," she added in a university news release. "These people represent an important group to provide information about treatment options." For the study, the researchers surveyed about 2,500 women who had ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Femara, Lupron Depot, Gleevec, Breast Cancer, Metastatic, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Tasigna, Megace, Sprycel, Herceptin

FDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer Patients

Posted 5 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – More cancer patients may be able to ward off hair loss during chemotherapy treatment. A cooling cap approved in 2015 for use in breast cancer patients has won expanded approval from the U.S. Food and Drug Administration. The DigniCap Cooling System can now be used for patients with solid tumors, the FDA announced. The computer-controlled cap contains liquid that circulates and cools the scalp, narrowing blood vessels. This reduces how much of the chemotherapy drugs reach hair follicle cells, the FDA said. Cooling also decreases activity of hair follicles and slows cell division. The result: Chemo drugs don't affect them as much, according to the FDA. Hair loss is a common side effect of chemotherapy, especially during treatment of most solid tumor cancers. Hair may fall out all at once, little by little or become thin. It's usually temporary – and upsetting. ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Femara, Lupron Depot, Gleevec, Breast Cancer, Metastatic, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Tasigna, Megace, Sprycel, Herceptin

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Rituxan, Gleevec, Isotretinoin, Colorectal Cancer

Anabolic Steroids May Tax the Heart

Posted 22 May 2017 by Drugs.com

MONDAY, May 22, 2017 – Long-term use of muscle-building anabolic steroids may take a toll on the heart, researchers say. Bodybuilders who take these drugs to bulk up should take note: prolonged use of anabolic steroids makes it harder for the heart to function properly. The steroids might also contribute to artery-clogging, study findings showed. "It is critical that clinicians become aware of the long-term risks of anabolic steroid use on the heart," said Dr. Harrison Pope Jr., a professor of psychiatry at Harvard Medical School and co-lead author of the study. Anabolic steroids are synthetic variations of the male hormone testosterone. An estimated 2.9 million to 4 million Americans have used these drugs, and about one million are dependent on the pills or injections, the researchers said. For the new study, Pope and his colleagues tracked 140 male weight-lifters. Eighty-six had used ... Read more

Related support groups: Muscle Pain, Testosterone, AndroGel, Testim, Axiron, Frozen Shoulder, Androderm, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Depo-Testosterone, Fortesta, Testopel, Methyltestosterone, Testopel Pellets, Stanozolol, Android, Oxandrolone, Winstrol, Durabolin, Delatestryl

Testosterone Therapy May Have Benefits, But Risks Too

Posted 21 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – Testosterone treatment can boost bone density and reduce anemia in older men with low levels of the hormone, but it might also open the door to future heart risks, a new set of trials suggests. The findings come in the last four studies to be reported out of the Testosterone Trials, a set of seven overlapping federally funded year-long clinical trials conducted at 12 sites across the United States. All told, the Testosterone Trials seem to indicate that the best use of testosterone therapy is for treatment of decreased sexual function in men with so-called "low T" (low testosterone levels), said Dr. Thomas Gill. He is a Yale University professor of geriatrics who ran one of the clinical trial sites. But the trials also found that men receiving testosterone treatment experienced a significantly greater increase in arterial plaque than men not taking the hormone, ... Read more

Related support groups: Heart Disease, Heart Attack, Testosterone, AndroGel, Testim, Axiron, Myocardial Infarction, Androderm, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Depo-Testosterone, Fortesta, Testopel, Testopel Pellets, Android, Methyltestosterone, Stanozolol, Ischemic Heart Disease, Winstrol, Oxandrolone

HRT Won't Lower Women's Alzheimer's Risk, Study Finds

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – Women who use hormone therapy after menopause may not have a lower risk of developing Alzheimer's, a new study suggests. However, there was some evidence that long-term use – over a decade – might be tied to a lower risk of the memory-robbing brain disease. But the results were far from definitive, the researchers added. The study is the latest to delve into the question of whether menopausal hormone therapy can benefit women's brains. Research so far has yielded conflicting findings. On one hand, a number of trials have found no brain benefits for women using hormone therapy, said Dr. JoAnn Pinkerton, executive director of the North American Menopause Society. On the other hand, small trials have found that when hormone therapy is given after surgical menopause, women can see "cognitive benefits," said Pinkerton, who was not involved in the new study. On ... Read more

Related support groups: Plan B, Mirena, Nexplanon, Depo-Provera, Provera, NuvaRing, Sprintec, Implanon, Ortho Tri-Cyclen, Hot Flashes, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra, Lutera, TriNessa, Menopausal Disorders, Estradiol

'Chemo Brain' Lasts for Months in Many Breast Cancer Survivors

Posted 11 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 11, 2017 – "Chemo brain" – the mental fog common after breast cancer treatment – can persist for six months, new research shows. The finding comes from one of the largest studies to date to look at chemotherapy-related thinking problems that plague many women treated for breast cancer. Those problems can include memory lapses, attention issues and difficulty processing information. When researchers compared hundreds of U.S. women six months after chemotherapy ended with hundreds of healthy women, they found more than one-third of the chemotherapy group had a decline in thinking scores versus less than 15 percent of the others. "The bottom line is, this is a real problem, patients are having difficulties and we need to acknowledge it is one of the difficulties of treatment," said Dr. Patricia Ganz. Ganz is director of cancer prevention and control research at the ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Megace, Herceptin, Aromasin, Afinitor

Study Casts More Doubt on Value of Mammograms

Posted 10 Jan 2017 by Drugs.com

MONDAY, Jan. 9, 2017 – Mammograms frequently detect small breast tumors that might never become life-threatening, causing women to receive treatment they likely don't need, a new Danish study finds. About one in every three women between the ages of 50 and 69 who was diagnosed with breast cancer wound up having a tumor that posed no immediate threat to her health, the researchers reported. At the same time, mammography did not reduce the number of advanced breast cancers found in women in the study. "This means that breast screening is unlikely to improve breast cancer survival or reduce the use of invasive surgery," said study author Dr. Karsten Juhl Jorgensen, deputy director of research for the Nordic Cochrane Center at the Rigshospitalet in Copenhagen. "It also means that breast screening leads to unnecessary detection and treatment of many breast cancers." Dr. Otis Brawley, chief ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Megace, Herceptin, Aromasin, Casodex, Exemestane, Eligard

Intense Chemo Offers Little Benefit for Early Breast Cancer: Study

Posted 9 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 9, 2016 – A more intense type of chemotherapy offers little benefit over standard chemotherapy for women with high-risk early breast cancer, European researchers report. Known as tailored dose-dense chemotherapy, the treatments are given over a shorter period of time without increasing the overall dose. It has been suggested as a way to improve the effectiveness of the treatment for early breast cancer. However, the European study did not find a difference in recurrence-free survival or overall survival after five years of follow-up. The investigators did find that the dose-dense group had better event-free survival, defined as the time to any breast cancer relapse, cancer in the opposite breast, other malignant growths or death from any cause. Despite the results, a U.S. breast cancer expert said there is still a role for the approach in certain women. Researchers from ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Megace, Herceptin, Aromasin, Casodex, Breast Cancer - Adjuvant

FDA Warns of Dangers From Testosterone Supplements

Posted 26 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – Supplemental testosterone and related anabolic-androgenic steroids (AAS) can cause heart attacks, personality changes and infertility, and are easily abused, the U.S. Food and Drug Administration warns. The agency said Monday that labeling on all prescription testosterone products – which are approved to treat men with low testosterone due to certain medical conditions – will be revised. Millions of American men currently use testosterone pills, gels or get injections in hopes of boosting their physical health or libido. Anabolic steroids are synthetic variations of testosterone and are legally prescribed to treat conditions such as delayed puberty and diseases that cause muscle loss, such as cancer or AIDS. But "testosterone and other AAS are abused by adults and adolescents, including athletes and body builders," according to an FDA news release. "Abuse ... Read more

Related support groups: Depression, Sleep Disorders, Insomnia, Fatigue, Erectile Dysfunction, Testosterone, Drug Dependence, AndroGel, Agitation, Testim, Alcoholism, Axiron, Substance Abuse, Androderm, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Depo-Testosterone, Fortesta, Testopel, Sexual Deviations or Disorders

Bodybuilders' Steroid Abuse Linked to Pre-Diabetic Condition

Posted 14 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 14, 2016 – Weightlifters' abuse of anabolic steroids – synthetic drugs that closely mimic male sex hormones, such as testosterone – may also lead to insulin resistance, a new study suggests. Insulin resistance is a condition where the muscles, liver and fat cells don't use insulin properly, according to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It can lead to the development of type 2 diabetes, NIDDK says. A team of researchers led by Dr. Jon Rasmussen from Herlev University Hospital in Copenhagen investigated the effects of anabolic steroids on the belly fat and insulin sensitivity of 100 men who were 50 years old or younger. All of the men were involved in strength training. The researchers divided the men into three groups based on their use of anabolic steroids: 37 men were currently using the drugs, 33 had done so in the ... Read more

Related support groups: Testosterone, AndroGel, Insulin Resistance, Testim, Axiron, Pre-Diabetes, Androderm, Diabetes Mellitus, Depo-Testosterone, Fortesta, Testopel, Methyltestosterone, Testopel Pellets, Stanozolol, Android, Oxandrolone, Winstrol, Durabolin, Abnormal Glucose Tolerance, Delatestryl

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less able to afford cancer drugs than Americans, he said, even though U.S. monthly drug prices are about three to six times higher in the United States. That doesn't mean America came out on top in overall drug affordability, however. Developed nations such as Australia, England and Israel had the "best deal" in the world on cancer drugs, thanks to government programs that regulate drug pricing, the study found. "America is the wealthiest nation, but its drug prices are significantly higher – so much ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Tretinoin, Lupron Depot, Femara, Lung Cancer, Rituxan, Gleevec, Isotretinoin, Colorectal Cancer, Votrient

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Hypogonadism - Male, Breast Cancer, Breast Cancer - Palliative, Delayed Puberty - Male, Postmenopausal Symptoms

Halotestin Patient Information at Drugs.com